Aligned with the FDA on submitted protocol for 225Ac-PSMA (FPI-2265) Phase 2/3 registrational program for patients with metastatic castration-resistant.
By Ben Glickman Shares of Fusion Pharmaceuticals rose in post-market trading on Thursday after the company had a study protocol approved by regulators. The.
Fusion Pharmaceuticals Announces Clinical Program And Manufacturing Updates menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Area bibliophiles on what they loved in 2023 and what to read in 2024 ideastream.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ideastream.org Daily Mail and Mail on Sunday newspapers.
Sleep Now in the Fire: the Year in Climate counterpunch.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from counterpunch.org Daily Mail and Mail on Sunday newspapers.